Gandeeva Therapeutics
Vision
Gandeeva seeks to achieve transformative societal impact on public health by revolutionizing drug discovery and by lowering risks of late-stage clinical failures.
Approach
Gandeeva is a precision biotechnology company harnessing the power of cryo-electron microscopy (cryo-EM) and machine learning to advance drug discovery and development at scale. Gandeeva’s end-to-end platform combines prediction and experimentation to enable breakthroughs in precision medicine by visualizing and analyzing protein-drug interactions at unprecedented speed and in atomic detail - providing new insights into how disease-relevant proteins function and how they can be targeted.
Gandeeva Therapeutics is addressing
CEO:
Sriram Subramaniam, PhD
Founders:
Sriram Subramaniam, PhD
First investment:
May 2021